发明名称 Pharmaceutical agents for the treatment of cerebral amyloidosis
摘要 The invention relates to a compound of the following general formula (III): wherein: R 1 and R 2 each are one or more independent substituents selected from the group consisting of hydrogen, C1-C5 alkyl, C2-C5 alkenyl, C3-C5 cycloalkyl, C1-C5 alkoxy, C2-C5 alkynyl, halogen, C1-C5 haloalkyl, alkylamino, phenyl, nitro and carboxyl; R 3 is selected from the group consisting of amino, C1-C5 substituted amino and CH 2 ; n and m are independently an integer of from 0-5; or a pharmaceutically acceptable salt of such compound; a compound of the following general formula (IV): wherein: R 1 and R 2 each are one or more independent substituents selected from the group consisting of hydrogen, C1-C5 alkyl, C2-C5 alkenyl, C3-C5 cycloalkyl, C1-C5 alkoxy, C2-C5 alkynyl, halogen, C1-C5 haloalkyl, alkylamino, phenyl, nitro and ca rboxyl; R 3 and R 4 each are independent and selected from the group consisting of hydrogen and C1-C5 alkyl; n is an integer of from 1 to 5; or a pharmaceutically acceptable salt of such compound; a compound of the following general formula (V): wherein: R 1 and R 2 each are one or more independent substituents selected from the group consisting of hydrogen, C1-C5 alkyl, C2-C5 alkenyl, C3-C5 cycloalkyl, C1-C5 alkoxy, C2-C5 alkynyl, halogen, C1-C5 haloalkyl, alkylamino, phenyl, nitro and carboxyl; R 3 is selected from hydrogen and C1-C5 alkyl; R 4 is selected from hydrogen and C1-C5 alkyl; n is an integer of from 1 to 5 inclusive; or a pharmaceutically acceptable salt of such compound; and a compound of the following general formula (VI): wherein: R 1 and R 2 each are one or more independent substituents selected from the group consisting of hydrogen, C1-C5 alkyl, C2-C5 alkenyl, C3-C5 cycloalkyl, C1-C5 alkoxy, C2-C5 alkynyl, halogen, C1-C5 haloalkyl, alkylamino, phenyl, nitro and carboxyl; R3 and R4 each are independent and selected from hydrogen and C1-C5 alkyl; n is an integer of from 1 to 5 inclusive; or a pharmaceutically acceptable salt of such compound. Also compositions comprising the compounds III-VI as well as uses of said compounds.
申请公布号 EP1930308(A1) 申请公布日期 2008.06.11
申请号 EP20070021294 申请日期 1998.05.19
申请人 NYMOX CORPORATION 发明人 AVERBACK, PAUL;GHANBARI, HOSSEIN;BEHESHTI, IRAJ;MORSE, DAVID
分类号 C07C43/164;C07D295/02;A61K31/075;A61K31/08;A61K31/138;A61K31/44;A61K31/445;A61K31/495;A61K31/52;A61K31/522;A61K45/00;A61P25/28;C07C43/17;C07C43/174;C07C43/178;C07C211/28;C07C217/10;C07D211/90;C07D295/03;C07D295/06;C07D295/08;C07D473/04 主分类号 C07C43/164
代理机构 代理人
主权项
地址